Cerus CERS
NASDAQ CERS
$2.51 -0.03 (-1.18%)
As of: Sep 9, 2026 · 3:59 PM EDT

Cerus (CERS) Restructuring Costs (2010)

Cerus' (CERS) quarterly Restructuring Costs came in at -$182000.0 in Q4 2010, up 9.45% quarter-over-quarter from -$201000.0 in Q3 2010.

Analysis

Cerus (CERS) Restructuring Costs (2010) Analysis & Trends

Cerus has disclosed Restructuring Costs across 1 years of filings, most recently posting -$182000.0 for Q4 2010.

  • In Q4 2010, Restructuring Costs changed N/A year-over-year to -$182000.0; the TTM figure through Dec 2011 stood at -$182000.0 (changed N/A YoY), while the FY2009 annual figure was $841000.0, changed N/A from the prior year.
  • Restructuring Costs came in at -$182000.0 for Q4 2010 at Cerus, up from -$201000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $132000.0 in Q2 2010 to a low of -$201000.0 in Q3 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Cerus 504.42 Mn 448.16 Mn 29.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -182,000.00
Sep 30, 2010 -201,000.00
Jun 30, 2010 132,000.00